Literature DB >> 18392551

Sacral neuromodulation reprogramming: is it an office burden?

Frank N Burks1, Ananais C Diokno, Michelle J Lajiness, Ibrahim A Ibrahim, Kenneth M Peters.   

Abstract

Our objective was to evaluate the burden of sacral neuromodulation (SNM) reprogramming and the reasons for reprogramming, and to correlate these with the underlying diagnosis. A retrospective review of 50 consecutive subjects implanted with SNM was completed from November 2002 through December 2005. Of the 50 SNM implants, 47 subjects had adequate follow-up. The mean age was 53.1 (22-90 years) with 83% women. Of the SNM performed, 91.5% were done for urinary urgency, frequency, or incontinence and 47.4% of those had interstitial cystitis. Overall, 239 programming visits were recorded, and subjects on average had two reprogramming visits per year. There was no correlation with number of reprogramming events and patient age, sex, reason for implantation, or diagnosis. These data suggest that the number of reprogramming episodes is small, and the majority is done as part of routine follow-up. No additional burden was seen in subjects with interstitial cystitis.

Entities:  

Mesh:

Year:  2008        PMID: 18392551     DOI: 10.1007/s00192-008-0601-3

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  4 in total

1.  Complications and troubleshooting of two-stage sacral neuromodulation therapy: a single-institution experience.

Authors:  Adonis Hijaz; Sandip P Vasavada; Firouz Daneshgari; Hasan Frinjari; Howard Goldman; Raymond Rackley
Journal:  Urology       Date:  2006-09-18       Impact factor: 2.649

Review 2.  Expanding indications for neuromodulation.

Authors:  Andrew J Bernstein; Kenneth M Peters
Journal:  Urol Clin North Am       Date:  2005-02       Impact factor: 2.241

3.  Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study.

Authors:  Craig V Comiter
Journal:  J Urol       Date:  2003-04       Impact factor: 7.450

4.  Predictive factors for sacral neuromodulation in chronic lower urinary tract dysfunction.

Authors:  W A Scheepens; M M G J Jongen; F H M Nieman; R A de Bie; E H J Weil; P E V van Kerrebroeck
Journal:  Urology       Date:  2002-10       Impact factor: 2.649

  4 in total
  11 in total

Review 1.  Sacral nerve stimulation in the elderly.

Authors:  Tomas L Griebling
Journal:  Int Urogynecol J       Date:  2010-12       Impact factor: 2.894

2.  [Sacral neuromodulation for refractory overactive bladder].

Authors:  Arndt van Ophoven
Journal:  Urologe A       Date:  2018-11       Impact factor: 0.639

3.  Minimum 6-year outcomes for interstitial cystitis treated with sacral neuromodulation.

Authors:  Serge P Marinkovic; Lisa M Gillen; Christina M Marinkovic
Journal:  Int Urogynecol J       Date:  2010-09-17       Impact factor: 2.894

4.  Sacral neuromodulation in patients with multiple sclerosis.

Authors:  Daniele Minardi; Giovanni Muzzonigro
Journal:  World J Urol       Date:  2011-03-15       Impact factor: 4.226

Review 5.  What's new in the diagnosis and management of painful bladder syndrome/interstitial cystitis?

Authors:  Abhishek Seth; Joel M H Teichman
Journal:  Curr Urol Rep       Date:  2008-09       Impact factor: 3.092

6.  Cycling Versus Continuous Mode In Neuromodulator Programming: A Crossover, Randomized, Controlled Trial.

Authors:  Gwendolyn M Beer; Margaret M Gurule; Yuko M Komesu; Clifford R Qualls; Rebecca G Rogers
Journal:  Urol Nurs       Date:  2016 May-Jun

7.  Sacral neuromodulation for multiple sclerosis patients with urinary retention and clean intermittent catheterization.

Authors:  Serge P Marinkovic; Lisa M Gillen
Journal:  Int Urogynecol J       Date:  2009-10-30       Impact factor: 2.894

8.  Sacral neuromodulation and peripheral nerve stimulation in patients with anal incontinence: an overview of techniques, complications and troubleshooting.

Authors:  Andrew P Zbar
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-04-10

Review 9.  Programming Algorithms for Sacral Neuromodulation: Clinical Practice and Evidence-Recommendations for Day-to-Day Practice.

Authors:  Paul A Lehur; Michael Sørensen; Thomas C Dudding; Charles H Knowles; Stefan de Wachter; Stefan Engelberg; Klaus E Matzel
Journal:  Neuromodulation       Date:  2020-03-09

Review 10.  Reprogramming Sacral Neuromodulation for Sub-Optimal Outcomes: Evidence and Recommendations for Clinical Practice.

Authors:  Thomas C Dudding; Paul A Lehur; Michael Sørensen; Stefan Engelberg; Maria Paola Bertapelle; Emmanuel Chartier-Kastler; Karel Everaert; Philip Van Kerrebroeck; Charles H Knowles; Lilli Lundby; Klaus E Matzel; Arantxa Muñoz-Duyos; Mona B Rydningen; Stefan de Wachter
Journal:  Neuromodulation       Date:  2021-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.